Navigation Links
Pfizer Acquires Worldwide Rights For New Overactive Bladder Drug

Pfizer Inc announced an agreement with Schwarz Pharma AG under which it would be acquiring exclusive worldwide rights to fesoterodine, a new drug that can be a treatment option for an overactive bladder. //

"Overactive bladder is a debilitating condition that affects up to 100 million people around the world," said Karen Katen, vice chairman of Pfizer Inc and president, Pfizer Human Health. "We are excited about the potential of this new medicine to offer patients and their doctors a new alternative to existing therapies for managing the symptoms of overactive bladder." Schwarz had submitted an application for fesoterodine approval to both the US Food and Drug Administration and the European Medicines Evaluation Agency (EMEA) earlier this year. Initially Pfizer will pay $100 million to Schwarz Pharma. This amount can be increased provided the drug meets certain milestones. Royalties of both fesoterodine and Pfizer's Detrol product line for treatment of overactive bladder will be paid to Schwarz. Pfizer's Detrol LA is a leading drug that helps control involuntary bladder contractions and decreases the symptoms of urgency with or without frequency and incontinence. Since its introduction it has been prescribed to over 11 million patients worldwide.
'"/>




Page: 1

Related medicine news :

1. Pfizer unveils anti-smoking drug
2. The Effectiveness Of The Breast Cancer Drug By Pfizer
3. New Drug Exubera (Oral Inhaled Insulin) To Be Monitored By Pfizer
4. Erectile Dysfunction Drug Viagra Launched In India By Pfizer
5. Pfizer’s Eraxis Approved By The FD
6. Pfizer Launches Viagra For Lung Disease In UK
7. Pfizer Commences Its Advertising for Celebrex with All the Warnings
8. FDA Approves Pfizer’s Anti-smoking Dru
9. Pfizer vouches safety of long-term inhaled insulin.
10. NICE Setback Rules for Pfizers Inhaled Insulin
11. Patency On Two Drugs From Merck & Pfizer’s To Expire Soo
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/20/2017)... ... 19, 2017 , ... Adolfson & Peterson Construction (AP) continues ... As a leader in healthcare construction, AP has successfully built several well-known medical ... Midwest with Josh now on board. , Josh brings over nine years ...
(Date:7/18/2017)... ... July 18, 2017 , ... CannaKids, a California Cooperative Cooperation that specializes in ... at the WORLDZ Summit, taking place in Hollywood from July 31-August 1, the ... medical cannabis for both pediatric and adult patients, and how the path has led ...
(Date:7/18/2017)... ... ... An inventor from Anacortes, Wash., knows the difficulties and indignity of not being ... I suffer from anxiety and vertigo on top of that," she said, "so I ... meets that need. , This device enables a woman in menopause to cool off ...
(Date:7/17/2017)... , ... July 17, 2017 , ... ... Depression and Its Treatments during Pregnancy , studies take a closer look at ... on a developing baby with one study showing newer medications may be safer ...
(Date:7/17/2017)... (PRWEB) , ... July 17, 2017 , ... ... medical education events, today announced a partnership with the Texas Academy of ... meeting will take place October 20-22, 2017 at the Hyatt Regency Dallas in ...
Breaking Medicine News(10 mins):
(Date:7/13/2017)... Products, a leader in medical product innovation and global patient care, ... hospice patient care. ... Centurion Medical Products ... management and emotional comfort are part of a hospice,s primary mission. ... unneeded emergency department admission due to severe fecal impaction. One of ...
(Date:7/11/2017)... Calif. , July 11, 2017 Zymo Research Corp., also ... service that can quantify biological aging in a precise manner using the ... Steve Horvath , a professor of human genetics and biostatistics at ... Fielding School of Public Health , Zymo Research,s proprietary DNAge ™ ... ...
(Date:7/11/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... on the development of oral drug delivery systems, announced ... has agreed to schedule an End-of-Phase II meeting with ... its oral insulin capsule ORMD-0801 in the treatment of ... and secondary endpoints by indicating a statistically significant lowering ...
Breaking Medicine Technology: